Search
Close this search box.

August 1, 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]

Read More

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon, marking a new era of […]

Read More

A 5-magnitude earthquake hits Konya, in central Turkey

An earthquake measuring 5 on the Richter scale hit this afternoon, Tuesday, the state of Konya, in central Turkey.The Turkish Disaster and Emergency Management Agency, AFAD, said in a statement that the earthquake occurred at 18:06 local time, with it…

Read More

Qatar Charity Implements 50 Water Projects in Somalia

Qatar Charity (QC) announced Tuesday it had implemented 50 water projects in Somalia at a cost of QAR 2.7 million.These projects were implemented this year in the states of Hirshabelle and Galmudug and included the drilling of 50 wells to meet the loc…

Read More

Popular Post

Categories

Advertisements